Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBIT: 2020-2025

Historic EBIT for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $19.0 million.

  • Cellebrite DI's EBIT fell 2.34% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.4 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $56.9 million for FY2024, which is 71.21% up from last year.
  • Latest data reveals that Cellebrite DI reported EBIT of $19.0 million as of Q3 2025, which was up 31.72% from $14.4 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's EBIT registered a high of $19.4 million during Q3 2024, and its lowest value of $136,000 during Q1 2023.
  • Its 3-year average for EBIT is $12.3 million, with a median of $13.5 million in 2023.
  • Per our database at Business Quant, Cellebrite DI's EBIT plummeted by 93.01% in 2023 and then spiked by 6,699.26% in 2024.
  • Over the past 5 years, Cellebrite DI's EBIT (Quarterly) stood at $4.3 million in 2021, then soared by 124.66% to $9.7 million in 2022, then skyrocketed by 55.04% to $15.0 million in 2023, then grew by 4.85% to $15.7 million in 2024, then fell by 2.34% to $19.0 million in 2025.
  • Its EBIT stands at $19.0 million for Q3 2025, versus $14.4 million for Q2 2025 and $12.3 million for Q1 2025.